🔗 Share this article

A shadow market for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, according to recent findings.

Experimental Drug Acquiring Traction Online

Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its alleged weight-reducing effects. Followers are encouraged to message these accounts privately for supplier links, while also obtaining promotional offers.

Active Commerce on Messaging Platforms

Additionally, a flourishing trade exists on messaging services, where groups with numerous of participants share “before and after” photos, injection guides and assertions of rapid British shipping. Vendors promote the drug there before directing customers to other platforms for transactions.

Understanding Retatrutide

Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could assist individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.

Medical Professionals Express Concerns

Nevertheless, doctors and chemists have warned that the sale of what is still an unlicensed medication in the United Kingdom is worrisome and could result in individuals administering products of unknown origin.

Some professionals said the popularity for the experimental drug could be connected to the rising cost of licensed weight loss products such as Mounjaro.

Legal Status and Enforcement

Selling retatrutide on social media or Telegram is prohibited in the UK, as it is an unapproved medication that cannot be marketed or supplied for human use under the Human Medicines Regulations 2012.

Several influencers attempt to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and distribution can still violate pharmaceutical, marketing, and consumer regulations, potentially leading to fines, prosecution or imprisonment.

Service Reaction and Material Elimination

Based on TikTok, the service has taken down problematic material and prohibited associated keywords and query recommendations. The organization stated it was committed to maintaining the platform safe and allocating resources in enhancing compliance measures.

Digital Trading Activities

Investigations also discovered groups with up to 9,000 participants marketing retatrutide using the platform's built-in discovery tool, which operates like a public directory. Typing “retatrutide” immediately brings up channels with thousands of members, filled with images of weight loss, positive reviews and detailed instructions for mixing or administering at home.

After minutes of joining one group, a seller shared contact information, where most purchases occur. The seller provided an guidebook and promised shipping within 48 hours. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None asked about body mass, health issues or previous experience.

Item Details and Pricing

Within these communities, messages show dark colored packages with postal service stickers, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at residence with sterile water, or ready-to-use pens typically priced at £160 for 20mg. When asked how long a pen should be used, vendors give conflicting answers ranging from a several days to “depends on your body”.

Service Moderation and Security Actions

A representative for the messaging service stated it regularly monitored dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are administering materials they cannot confirm. Even if the science behind this drug is valid, these online products may not include what they advertise,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the increase in interest to recent cost increases for approved weight-loss drugs such as Mounjaro. “With prices increasing, individuals are using social media. But fake injections are highly dangerous. You cannot know what’s contained or whether the environment they were produced in was sterile,” she said.

Her staff has already encountered individuals injured by personal administration from unconfirmed sources. “We recognize the disappointment, but purchasing from Telegram or WhatsApp is gambling with your health,” said the doctor. “These substances could be impure or improperly measured.”

Manufacturer Position

A representative from Eli Lilly said retatrutide was in phase 3 research studies and had not been evaluated or approved by any regulatory agency globally. “Therefore at this time no one can market [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a company experimental substance not yet approved … may subject patients to potentially significant health risks”.